TEG

Answerthink and LORENZ Life Sciences Group Announce Strategic Alliance for the SAP Life Science Industry

MIAMI--(BUSINESS WIRE)--Jun 21, 2007 - Answerthink, Inc. (NASDAQ:ANSR) announced today that it has formed a strategic alliance withLORENZ Life Sciences Group for the distribution of LORENZ solutionsin North America. Answerthink and LORENZ Life Sciences Group willserve midsize companies by integrating best practice submissionsmanagement solutions into Answerthink's Life Science solutionsbase...

Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting

MONTREAL, QUEBEC--(CCNMatthews - June 14, 2007) - AmbriliaBiopharma Inc. (TSX:AMB), a biopharmaceutical company developingnovel small molecules and peptides to treat infectious diseases andcancer, held its Annual General and Special Meeting today, duringwhich the data reported yesterday on its novel series of HIVintegrase inhibitors and recent developments were highlighted. Themeeting wa...

Generex Biotechnology Vaccine Strategy Presented at International Conference in London

WORCESTER, MA - May 24, 2007 - Generex Biotechnology Corporation(NasdaqCM:GNBT) announced today that Dr. Douglas Powell, Directorof Immunobiology at its wholly-owned Antigen Express subsidiary,has presented Antigen's vaccine development strategy at aninternational conference in London, UK. The international meeting,"Developing New Anti-Infective Agents - Challenges andOpportunities" (<a...

Schepens Scientists Identify Key to Integrating Transplanted Nerve Cells Into Injured Tissue

Discovery promises to make retina, spinal cord and other centralnervous system transplants possible BOSTON, April 26, 2007 /PRNewswire/ -- Scientists at theSchepens Eye Research Institute, an affiliate of Harvard MedicalSchool, have identified a key mechanism for successfullytransplanting tissue into the adult central nervous system. Thestudy found that a molecule known as MMP-2 (which is...

Study Shows Metabolic Strategy of Stressed Cell

Major St. Jude Study of Changes in Gene Activity and MetabolicEnzymes Show How Cells Respond to a Sudden Decrease in the Levelsof Coenzyme A, a Key Player in the Daily Biochemical Routines thatSupport Life MEMPHIS, Tenn., March 23, 2007 /PRNewswire/ -- Investigators atSt. Jude Children's Research Hospital have mapped out many of thedynamic genetic and biochemical changes that make up a ce...

Integrated Biopharma's Proprietary Vaccine Technology Achieves Strong Positive Results

HILLSIDE, N.J., March 12, 2007 /PRNewswire-FirstCall/ --InB:Biotechnologies, Inc. ("BioTech"), a wholly-owned subsidiary ofIntegrated BioPharma, Inc. , today announced strong positiveresults in studies of vaccines against HPV, anthrax and plague madeusing INBP's novel, proprietary AIPwLV(TM) vaccine technology. Thestudies were conducted by the Fraunhofer USA Center for MolecularBiotechno...

Integrated BioPharma's Proprietary Vaccine Technology Achieves Strong Positive Results

HILLSIDE, NJ, March 12, 2007—InB:Biotechnologies, Inc.("BioTech"), a wholly-owned subsidiary of Integrated BioPharma,Inc. (NASDAQ: INBP), today announced strong positive results instudies of vaccines against HPV, anthrax and plague made usingINBP's novel, proprietary AIPwLV™ vaccine technology. Thestudies were conducted by the Fraunhofer USA Center for MolecularBiotechnology...